BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 12894498)

  • 1. Her2/neu expression in C-cell hyperplasia and medullary thyroid carcinomas.
    Ensinger C; Prommegger R; Kendler D; Gabriel M; Spizzo G; Mikuz G; Kremser R
    Anticancer Res; 2003; 23(3B):2241-3. PubMed ID: 12894498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Her2/neu expression in poorly-differentiated and anaplastic thyroid carcinomas.
    Ensinger C; Prommegger R; Kendler D; Gabriel M; Spizzo G; Mikuz G; Kremser R
    Anticancer Res; 2003; 23(3B):2349-53. PubMed ID: 12894514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of calcitonin-containing parafollicular cells of the thyroid in patients with chronic lymphocytic thyroiditis: a clinical, pathological and immunohistochemical study.
    Lukács G; Sápy Z; Gyóry F; Tóth V; Balázs G
    Acta Chir Hung; 1997; 36(1-4):204-6. PubMed ID: 9408347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of polysomy 17 in transitional cell carcinoma of the bladder: immunohistochemical study of HER2/neu expression and fish analysis of c-erbB-2 gene and chromosome 17.
    Simonetti S; Russo R; Ciancia G; Altieri V; De Rosa G; Insabato L
    Int J Surg Pathol; 2009 Jun; 17(3):198-205. PubMed ID: 19443884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The C-cells: current concepts on normal histology and hyperplasia.
    Borda A; Berger N; Turcu M; Al Jaradi M; Vereş S
    Rom J Morphol Embryol; 1999-2004; 45():53-61. PubMed ID: 15847379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ghrelin in human medullary thyroid carcinomas.
    Morpurgo PS; Cappiello V; Verga U; Vicentini L; Vaghi I; Lauri E; Nebuloni M; Beck-Peccoz P; Spada A
    Clin Endocrinol (Oxf); 2005 Oct; 63(4):437-41. PubMed ID: 16181236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of c-erbB-2 expression in papillary thyroid carcinoma.
    Freudenberg LS; Sheu S; Görges R; Mann K; Bokler S; Frilling A; Schmid KW; Bockisch A; Otterbach F
    Nuklearmedizin; 2005; 44(5):179-82, 184. PubMed ID: 16395492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HER2/neu (c-erbB-2) gene amplification and protein expression are rare in uterine cervical neoplasia: a tissue microarray study of 814 archival specimens.
    Lesnikova I; Lidang M; Hamilton-Dutoit S; Koch J
    APMIS; 2009 Oct; 117(10):737-45. PubMed ID: 19775342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proliferative activity in C-cell hyperplasia and medullary thyroid carcinoma. Evaluation by PCNA immunohistochemistry and AgNORs staining.
    Matias-Guiu X; Peiro G; Esquius J; Oliva E; Cabezas R; Colomer A; Prat J
    Pathol Res Pract; 1995 Feb; 191(1):42-7. PubMed ID: 7651932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiogenesis and c-erbB-2 (HER2/neu) overexpression status in primary breast cancer patients: an analysis of 158 needle core biopsies.
    Vameşu S
    Rom J Morphol Embryol; 2007; 48(2):121-9. PubMed ID: 17641798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological relevance of HER2/neu and a related gene-protein cubic regression correlation in colorectal adenocarcinomas in Taiwan.
    Li JW; Chuang TC; Yang AH; Hsu CK; Kao MC
    Int J Oncol; 2005 Apr; 26(4):933-43. PubMed ID: 15753987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor histology and stage but not p53, Her2-neu or cathepsin-D expression are independent prognostic factors in breast cancer patients.
    Korkolis DP; Tsoli E; Fouskakis D; Yiotis J; Koullias GJ; Giannopoulos D; Papalambros E; Nikiteas NI; Spiliopoulou CA; Patsouris E; Asimacopoulos P; Gorgoulis VG
    Anticancer Res; 2004; 24(3b):2061-8. PubMed ID: 15274401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-cell hyperplasia accompanying thyroid diseases other than medullary carcinoma: an immunocytochemical study by means of antibodies to calcitonin and somatostatin.
    Scopsi L; Di Palma S; Ferrari C; Holst JJ; Rehfeld JF; Rilke F
    Mod Pathol; 1991 May; 4(3):297-304. PubMed ID: 1676840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of Her2/neu in locally advanced bladder cancer: implication for a molecular targeted therapy].
    Wülfing C; von Struensee D; Bierer S; Bögemann M; Hertle L; Eltze E
    Aktuelle Urol; 2005 Sep; 36(5):423-9. PubMed ID: 16163605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the cholecystokinin 2-receptor in normal human thyroid gland and medullary thyroid carcinoma.
    Blaker M; de Weerth A; Tometten M; Schulz M; Höppner W; Arlt D; Hoang-Vu C; Dralle H; Terpe H; Jonas L; von Schrenck T
    Eur J Endocrinol; 2002 Jan; 146(1):89-96. PubMed ID: 11751073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression levels and clinical-pathological correlations of HER2/neu in primary and metastatic human breast cancer.
    Stefano R; Agostara B; Calabrò M; Campisi I; Ravazzolo B; Traina A; Miele M; Castagnetta L
    Ann N Y Acad Sci; 2004 Dec; 1028():463-72. PubMed ID: 15650272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclooxygenase-2 expression in medullary thyroid carcinoma.
    Popovtzer A; Morgenstein S; Roizman P; Gutman D; Bahar G; Stern Y; Feinmesser R
    Head Neck; 2007 Jun; 29(6):559-63. PubMed ID: 17274057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid carcinomas with mixed follicular and C-cell differentiation patterns.
    Papotti M; Volante M; Komminoth P; Sobrinho-Simões M; Bussolati G
    Semin Diagn Pathol; 2000 May; 17(2):109-19. PubMed ID: 10839611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HER-2/Neu alterations in non-small cell lung cancer: a comprehensive evaluation by real time reverse transcription-PCR, fluorescence in situ hybridization, and immunohistochemistry.
    Pellegrini C; Falleni M; Marchetti A; Cassani B; Miozzo M; Buttitta F; Roncalli M; Coggi G; Bosari S
    Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3645-52. PubMed ID: 14506153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous hidradenocarcinoma: a clinicopathological, immunohistochemical, and molecular biologic study of 14 cases, including Her2/neu gene expression/amplification, TP53 gene mutation analysis, and t(11;19) translocation.
    Kazakov DV; Ivan D; Kutzner H; Spagnolo DV; Grossmann P; Vanecek T; Sima R; Kacerovska D; Shelekhova KV; Denisjuk N; Hillen U; Kuroda N; Mukensnabl P; Danis D; Michal M
    Am J Dermatopathol; 2009 May; 31(3):236-47. PubMed ID: 19384064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.